Difference between revisions of "CT Coordinating Committee"

From QIBA Wiki
Jump to navigation Jump to search
Line 10: Line 10:
 
:* Approving for publication Biomarker Profiles developed by the CT Biomarker Committees
 
:* Approving for publication Biomarker Profiles developed by the CT Biomarker Committees
 
::* [[CT Volumetry Biomarker Ctte]]
 
::* [[CT Volumetry Biomarker Ctte]]
 +
:::* [[CT_Volumetry_Biomarker_Ctte#Lung_Nodule_Assessment_in_CT_Screening|Lung Nodule Assessment in CT Screening]]
 
::* [[Lung Density Biomarker Ctte]]
 
::* [[Lung Density Biomarker Ctte]]
  

Revision as of 18:04, 13 February 2017

Chairs: Gregory Goldmacher, MD, PhD, MBA (Co-Chair), Lawrence Schwartz, MD (Co-chair), David Lynch, MD (Vice-chair)
Secretary: Susan Weinmann (RSNA Staff)
Roster: <link to roster of active attendees and who has voting privileges>

Scope

The CT Coordinating Committee coordinates Biomarker Committees based on CT.

  • Considering and proposing new candidate Biomarker Committees to the Steering Committee
  • Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee
  • Approving for publication Biomarker Profiles developed by the CT Biomarker Committees

Meetings